Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH
Status:
Completed
Trial end date:
2019-12-20
Target enrollment:
Participant gender:
Summary
To compare the therapeutic equivalence of Beclomethasone Dipropionate MDI (Inhalation
Aerosol) 0.04 mg/ INH with the marketed QVAR® 40 mcg (Beclomethasone dipropionate
hydrofluoroalkane (HFA)) and to demonstrate superiority of both active treatments over
placebo.